NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,000 | -98.0% | 24 | -97.7% | 0.00% | -100.0% |
Q3 2021 | $49,000 | +4.3% | 1,024 | -1.6% | 0.01% | 0.0% |
Q2 2021 | $47,000 | -6.0% | 1,041 | 0.0% | 0.01% | -20.0% |
Q1 2021 | $50,000 | -12.3% | 1,041 | -2.3% | 0.01% | -16.7% |
Q4 2020 | $57,000 | +46.2% | 1,066 | -0.2% | 0.01% | +33.3% |
Q3 2020 | $39,000 | +18.2% | 1,068 | 0.0% | 0.01% | +28.6% |
Q2 2020 | $33,000 | +10.0% | 1,068 | -1.8% | 0.01% | 0.0% |
Q1 2020 | $30,000 | +900.0% | 1,088 | +1136.4% | 0.01% | +600.0% |
Q4 2019 | $3,000 | +50.0% | 88 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 88 | +1.1% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 87 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | – | 87 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |